Genpact completes acquisition of Pharmalink Consulting

Now part of Genpact’s growing life sciences vertical, the new business is named Genpact Pharmalink Global Regulatory Affairs.

Genpact Pharmalink Global Regulatory Affairs combines Pharmalink’s specialized domain expertise in consulting, project support and outsourced regulatory affairs services with Genpact’s global delivery, BPO, technology and analytics offerings for the life sciences market.

Genpact’s expanded capabilities now support core life sciences R&D functions such as regulatory strategy, filings, complex compliance services, patient safety and management of post-licensing activities.

“Genpact is thrilled to add this extremely talented group of life sciences experts to our growing operations,” said Balkrishan Kalra, senior vice president and business leader, Life Sciences, Genpact. 

“We are confident that Genpact Pharmalink Global Regulatory Affairs will transform the way life sciences companies address the ongoing and complex challenges in the area of regulatory affairs," Kalra said.

“With significant cultural synergies that have been evident from the outset, our team across the US, UK, India, Ireland and Puerto Rico is excited to be officially part of Genpact,” said Kevin Webb, chief operating officer, Genpact Pharmalink Global Regulatory Affairs. 

Webb said: “We are already developing a next generation offering to meet growing needs within a rapidly-changing market.”